IRIS PubliCatt

Tursi, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 324
EU - Europa 272
AS - Asia 136
SA - Sud America 12
AF - Africa 1
Totale 745
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 318
IT - Italia 82
SG - Singapore 68
SE - Svezia 51
FR - Francia 30
IE - Irlanda 29
DE - Germania 28
CN - Cina 24
ID - Indonesia 22
UA - Ucraina 13
GB - Regno Unito 10
CO - Colombia 8
FI - Finlandia 8
IN - India 7
RU - Federazione Russa 7
KR - Corea 6
BE - Belgio 5
CA - Canada 5
BR - Brasile 4
CZ - Repubblica Ceca 3
IL - Israele 2
IR - Iran 2
JP - Giappone 2
LT - Lituania 2
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
LI - Liechtenstein 1
NG - Nigeria 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
TR - Turchia 1
Totale 745
Salva come PNG Salva come JPEG
Città #
Chandler 97
Singapore 55
Ashburn 30
Dublin 27
Jakarta 22
New York 22
Milan 20
Marseille 13
Rome 13
Los Angeles 10
Bogotá 8
Beijing 7
Munich 7
Paris 7
Princeton 7
Pune 7
Boardman 6
Boston 6
Jacksonville 6
Seoul 6
Brussels 5
Fairfield 5
Helsinki 5
Houston 5
Moscow 4
Redwood City 4
Seattle 4
Wilmington 4
Ann Arbor 3
Caxias do Sul 3
Chelsea 3
Monte Argentario 3
San Diego 3
San Mateo 3
Toronto 3
Verona 3
Washington 3
Bremen 2
Brno 2
Busto Arsizio 2
Cattolica 2
Chicago 2
Edinburgh 2
Florence 2
Hangzhou 2
Jiaxing 2
Lawrence 2
London 2
Nanjing 2
Nuremberg 2
Pescara 2
Saint-Fons 2
Alexandria 1
Andover 1
Arezzo 1
Arzachena 1
Augusta 1
Belize City 1
Brdo 1
Bucharest 1
Capoliveri 1
Carate Brianza 1
Changsha 1
Chiswick 1
Cormeilles-en-Parisis 1
Dearborn 1
Fortaleza 1
Frankfurt am Main 1
Gdansk 1
Grottaglie 1
Hebei 1
Huskvarna 1
Istanbul 1
Kaliningrad 1
Kish 1
Lagos 1
Lappeenranta 1
Las Vegas 1
Leawood 1
Massa 1
Montreal 1
Nagoya 1
Nanchang 1
Olongapo City 1
Ottawa 1
Santa Clara 1
Sofia 1
Tel Aviv 1
Tokyo 1
Torre del Lago Puccini 1
Trieste 1
University Park 1
Vaduz 1
Villongo 1
Woodbridge 1
Totale 512
Salva come PNG Salva come JPEG
Nome #
Effect of moderate and heavy alcohol consumption on intestinal transit time 85
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. 80
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease 65
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 64
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 54
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care 45
Intestinal Microbiome Modulation During Coronavirus Disease 2019: Another Chance to Manage the Disease? 45
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 38
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 37
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 36
Response to Jackson et al 32
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 28
Microbiota Composition in Diverticular Disease: Implications for Therapy 23
Microbiota Composition in Diverticular Disease: Implications for Therapy 21
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 19
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach 17
Prognostic performance of the ‘DICA’ endoscopic classification and the ‘CODA’ score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study 17
SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease 14
Prevalence and Natural History of Segmental Colitis Associated With Diverticulosis 13
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 13
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 12
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 11
International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease 3
Totale 772
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.262
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 1 0 4 1 1 0 4 3
2020/202123 0 2 7 3 3 1 1 0 2 0 3 1
2021/202281 3 2 0 0 1 1 2 4 3 18 23 24
2022/2023237 27 27 11 40 13 25 16 26 19 10 16 7
2023/2024235 9 43 23 17 8 31 21 4 18 22 28 11
2024/2025124 13 10 45 20 36 0 0 0 0 0 0 0
Totale 772